SynthesisFrontiers in cardiovascular medicine2022
Clinical and Echocardiographic Outcomes of Transcatheter Tricuspid Valve Interventions: A Systematic Review and Meta-Analysis.
Synthesis in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Advanced Imaging Assessment of the Impact of Tricuspid Regurgitation on Cardiac Remodeling: The TRILUMINATE Pivotal Imaging Substudy.Journal of the American College of Cardiology · 2025Trial
- Left atrial remodelling and diastolic unloading after transcatheter tricuspid repair.ESC heart failure · 2026Article
- 2D-Echocardiographic Estimation of Right Ventricular Volumes Using a Previously Validated Geometric Model Is Associated With Outcomes After Transcatheter Tricuspid Interventions.Echocardiography (Mount Kisco, N.Y.) · 2026Article
- Contemporary insights and evolving clinical pathways in transcatheter tricuspid valve replacement.Herz · 2026Review
- Article
- Prevalence and Impact of Diabetes Mellitus in Patients Undergoing Transcatheter Tricuspid Valve Repair Using the Edge-to-Edge Technique.Anatolian journal of cardiology · 2026Article
- The Two-Device Problem: A Comprehensive Framework for Managing Transvalvular CIED Leads in the Era of Transcatheter Tricuspid Intervention.Journal of clinical medicine · 2026Review
- Tricuspid valve edge to edge repair vs replacement - a comparative analysis and future directions.Future cardiology · 2026Review
- Right ventricular dysfunction in structural tricuspid interventions.European heart journal. Imaging methods and practice · 2025Review
- Tricuspid Regurgitation in the Era of Transcatheter Interventions: The Pivotal Role of Multimodality Imaging.Journal of clinical medicine · 2025Review
- Late referrals and high mortality in tricuspid regurgitation: a call for timely intervention.European heart journal open · 2025Article
- Sex Differences Among Patients Undergoing Transcatheter Tricuspid Valve Repair Using the Edge-to-Edge Technique.Journal of cardiovascular development and disease · 2024Article
- Efficacy and Safety of Cardioband in Patients with Tricuspid Regurgitation: Systematic Review and Meta-Analysis of Single-Arm Trials and Observational Studies.Journal of clinical medicine · 2024Review
- Transcatheter Tricuspid Valve Intervention for the Treatment of Tricuspid Regurgitation with TriClip: All You Need to Know.Heart international · 2024Review
- Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints.European heart journal · 2023Article
- Tricuspid Regurgitation: A New Transcatheter Therapy on the Block!JACC. Advances · 2023Article
- Tricuspid Leaflet Gap-Reduction Maneuvers During Transcatheter Tricuspid Valve Repair.JACC. Case reports · 2023Article
- New therapeutic approach for tricuspid regurgitation: Transcatheter tricuspid valve replacement or repair.Frontiers in cardiovascular medicine · 2023Review
- Multimodality imaging for transcatheter tricuspid valve repair and replacement.Frontiers in cardiovascular medicine · 2023Review
- Tricuspid Valve Regurgitation: Current Understanding and Novel Treatment Options.Journal of the Society for Cardiovascular Angiography & InterventionsReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Medically managed tricuspid regurgitation (TR) has detrimental outcomes. Transcatheter tricuspid valve interventions (TTVIs) represent an alternative to surgery in high-risk patients; however, only early experiences exist. Aim: The aim of this study was to analyze the clinical and echocardiographic outcomes of TTVI. Methods: MEDLINE, ISI Web of Science, and SCOPUS databases were searched for studies published up to June 2021. Studies reporting data on outcome post-TTVIs were included. This study was designed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) requirements. The primary endpoint was all-cause mortality at 30-day and 1-year post-TTVI. Results: Out of 2,718 studies, 27 were included. Notably, 30-day and 1-year all-cause mortalities were 5% (95% confidence interval [CI]: 4-8%, Conclusion: TTVI significantly reduces TR severity and increases FSV and is associated with improved survival at 1 year compared with patients without procedural success. Long-term outcomes compared with medical therapy await the results of ongoing pivotal trials; nonetheless, TTVIs appear to be a promising alternative to surgery for TR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.